- Report
- March 2024
- 200 Pages
Global
From €3771EUR$4,150USD£3,242GBP
- Report
- March 2024
- 200 Pages
Global
From €3771EUR$4,150USD£3,242GBP
- Report
- January 2024
- 200 Pages
Global
From €3771EUR$4,150USD£3,242GBP
- Report
- August 2023
- 145 Pages
Global
From €2862EUR$3,150USD£2,460GBP
- Report
- March 2022
- 300 Pages
Global
From €4543EUR$5,000USD£3,906GBP
- Report
- August 2025
- 185 Pages
Global
From €4089EUR$4,500USD£3,515GBP
- Report
- December 2024
- 85 Pages
Spain
From €3180EUR$3,500USD£2,734GBP
- Report
- October 2023
- 133 Pages
Europe
From €3635EUR$4,000USD£3,124GBP
- Report
- March 2024
- 200 Pages
Global
From €3771EUR$4,150USD£3,242GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1136EUR$1,250USD£976GBP
- Drug Pipelines
- April 2025
- 240 Pages
Global
From €2726EUR$3,000USD£2,343GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1817EUR$2,000USD£1,562GBP
- Report
- August 2024
- 150 Pages
Global
From €3407EUR$3,750USD£2,929GBP
- Report
- June 2024
- 200 Pages
Global
From €7224EUR$7,950USD£6,210GBP
- Report
- April 2024
- 30 Pages
Global
From €2953EUR$3,250USD£2,539GBP
- Report
- January 2024
- 189 Pages
Global
From €6815EUR$7,500USD£5,858GBP
- Report
- February 2023
- 107 Pages
Global
From €6815EUR$7,500USD£5,858GBP
- Report
- August 2026
- 70 Pages
India
From €4316EUR$4,750USD£3,710GBP
- Report
- August 2026
- 70 Pages
South Africa
From €4316EUR$4,750USD£3,710GBP
- Report
- August 2026
- 70 Pages
Saudi Arabia
From €4316EUR$4,750USD£3,710GBP

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more